Zobrazeno 1 - 10
of 161
pro vyhledávání: '"Thomas, Yorio"'
Publikováno v:
BMC Health Services Research, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Introduction The majority of metastatic renal cell carcinoma (mRCC) patients receive one or more VEGFR TKI agents, alone or in combination with an immune-oncology (IO) agent or an mTOR inhibitor. To date, the cost of adverse events (AEs) com
Externí odkaz:
https://doaj.org/article/8ef7bbd24a304d5b9b93e0aceb84d027
Autor:
Mabel Ryder, Mouhammed Amir Habra, Matthew Campbell, Sara Bedrose, Kevin Charles Miller, Lina Altameemi, Mohamed S Ali, Sameh Nassar, Naveen Garg, Marilyne Daher, Keith D Eaton, Jeffrey Thomas Yorio, Davey B Daniel, Keith C Bible, Ashish V Chintakuntlawar
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Background There is no effective systemic therapy for metastatic adrenal cortical carcinoma (ACC) after failure of platinum-based chemotherapy. The efficacies of single-agent oral multikinase inhibitors (MKIs) or salvage immune checkpoint inhibitors
Externí odkaz:
https://doaj.org/article/4a195cbe866047b8a6068d0918bac22f
Publikováno v:
ASPET 2023 Annual Meeting Abstract - Pharmacology Education.
Publikováno v:
PLoS ONE, Vol 12, Iss 9, p e0185390 (2017)
c-Jun, c-Jun N-terminal kinase(JNK) and endothelin B (ETB) receptor have been shown to contribute to the pathogenesis of glaucoma. Previously, we reported that an increase of c-Jun and CCAAT/enhancer binding protein β (C/EBPβ) immunohistostaining i
Externí odkaz:
https://doaj.org/article/03f0079fa86d46428a7bd742c92386c6
Publikováno v:
Expert Review of Ophthalmology. 15:145-157
Glucocorticoids (GCs) have unique actions in their combined anti-inflammatory and immunosuppressive activities and are among the most commonly prescribed drugs, particularly for inflammatory condit...
Publikováno v:
Journal of Clinical Oncology. 41:629-629
629 Background: Nearly all mRCC pts will be treated with one or more VEGFR TKI, alone or in combination with an immunotherapy (IO) or mTOR-inhibitor, during their therapeutic journey and may experience associated AEs. Evidence from the tivozanib (tiv
Publikováno v:
Ethn Dis
The National Science Foundation (NSF) reports that underrepresented minority students are just as interested as their White counterparts in majoring in science upon entering college.1 However, the numbers of those receiving bachelors’ degrees, atte
Autor:
Sara Bedrose, Kevin Charles Miller, Lina Altameemi, Mohamed S Ali, Sameh Nassar, Naveen Garg, Marilyne Daher, Keith D Eaton, Jeffrey Thomas Yorio, Davey B Daniel, Keith C Bible, Ashish V Chintakuntlawar, Mouhammed Amir Habra
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Publikováno v:
Investigative Ophthalmology & Visual Science
Purpose The purpose of this study was to determine the effects of the Sigma-1R (σ-1r) on retinal ganglion cell (RGC) survival following optic nerve crush (ONC) and the signaling mechanism involved in the σ-1r protection. Methods The overall strateg
Autor:
Sara Bedrose, Kevin Charles Miller, Lina Altameemi, Mohamed S Ali, Sameh Nassar, Naveen Garg, Marilyne Daher, Keith D Eaton, Jeffrey Thomas Yorio, Davey B Daniel, Keith C Bible, Ashish V Chintakuntlawar, Mouhammed Amir Habra
Publikováno v:
Borch, T H, Andersen, R, Ellebaek, E, Met, Ö, Donia, M & Marie Svane, I 2020, ' Future role for adoptive T-cell therapy in checkpoint inhibitor-resistant metastatic melanoma ', Journal for ImmunoTherapy of Cancer, vol. 8, no. 2, e000668 . https://doi.org/10.1136/jitc-2020-000668
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Journal for Immunotherapy of Cancer
Personalized cell therapy targeting tumor antigens with expanded tumor-infiltrating lymphocytes (TILs) has shown great promise in metastatic melanoma (MM) since the 90s. However, MM was first-in line to benefit from the wave of checkpoint inhibitors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d641d1c6c3ec4199fc33e86fc877d9a8
https://curis.ku.dk/ws/files/258770968/e000668.full.pdf
https://curis.ku.dk/ws/files/258770968/e000668.full.pdf